GlassScriptPhysician profile
Lewis H Holmes
NPI 1134173768
$2,232.00
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $443 · 2021: $543 · 2022: $158 · 2023: $738.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $738.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $737.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $308.50 | 2019-2023 | Tavneos, Parsabiv |
| Mallinckrodt Hospital Products INC. | $279.67 | 2020-2023 | Acthar |
| Otsuka America Pharmaceutical, INC. | $221.84 | 2019-2023 | Jynarque |
| Astrazeneca Pharmaceuticals LP | $214.04 | 2019-2023 | Farxiga, Lokelma |
| Horizon Therapeutics Plc | $173.02 | 2019-2023 | Krystexxa |
| Daiichi Sankyo INC. | $128.34 | 2019-2023 | Injectafer |
| Calliditas Therapeutics US INC. | $124.98 | 2023 | Tarpeyo |
| Vifor Pharma, INC. | $106.38 | 2020-2021 | |
| Glaxosmithkline, LLC. | $99.50 | 2021-2023 | Jesduvroq |
| Bayer Healthcare Pharmaceuticals INC. | $96.92 | 2022-2023 | |
| Alexion Pharmaceuticals, INC. | $71.16 | 2019-2023 | Ultomiris |
| Fresenius USA Marketing, INC. | $66.43 | 2019-2023 | Velphoro |
| Nxstage Medical, INC. | $57.00 | 2021 | |
| Akebia Therapeutics INC | $43.72 | 2020-2022 | |
| Travere Therapeutics, INC. | $39.79 | 2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aurinia Pharma U.S., INC. | $35.22 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $32.69 | 2020-2023 | Gattex |
| Shire North American Group INC | $31.41 | 2019 | |
| Genzyme Corporation | $18.94 | 2019 | |
| Opko Pharmaceuticals, LLC | $18.86 | 2023 | Rayaldee |
| Kyowa Kirin, INC. | $18.42 | 2023 | |
| Mallinckrodt Enterprises LLC | $16.48 | 2019 | |
| Baxter Healthcare | $14.55 | 2023 | Renal - Acute |
| Medtronic Vascular, INC. | $14.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lewis Holmes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.